Sarah Wakerell
London, ENG SW73RD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.
Journal: Genome medicine
Published: July 29, 2025
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.
Journal: The New England journal of medicine
Published: April 11, 2025
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival.
Journal: European urology oncology
Published: December 04, 2023
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes.
Journal: BJC reports
Published: September 19, 2023
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.
Journal: BJU international
Published: December 17, 2020
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
Journal: European urology oncology
Published: October 27, 2020
Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
Journal: British journal of cancer
Published: March 07, 2019
Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
Journal: European urology
Published: August 03, 2018
Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
Journal: British journal of cancer
Published: November 30, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026